RIBOGENE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RIBOGENE, covering 2016-05-13 to 2016-05-13. Get the full timeline:
Most recent: Clinical Trial Update: RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure [NA]